RecruitingNCT03655015

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (CTMS 18-0056)

Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

150 participants

Start Date

Oct 16, 2018

Study Type

OBSERVATIONAL

Conditions

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Min Age: 18 Years

Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
Any clinical stage of lung cancer
Adult patients ≥18 years of age
Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history

At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

PROCEDURELung Tumor Resection

Lung Tumor Resection

UT Health San Antonio, M.D. Anderson Cancer Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT03655015